United States · Investor

Eshelman Ventures

Last cheque observed Dec 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

SeedSeries ASeries BWellbeingHealthier LivingWell-being

Cheques on record
0%of best year0cheques in 12 months, 5 on record
Since the last cheque2503days00hrs00min00sec
Median round$44MRounds led0 of 5Sole investor2 roundsMostly inUnited States, 100%
Pitch Eshelman Ventures

Eshelman Ventures highlights

  1. 01

    5 rounds on record

  2. 02

    Mostly Series B and Series D: 75% of its rounds

  3. 03

    Sole investor in 2 rounds, median $21M

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
WellbeingHealthier LivingWell-being
Based in
Wilmington, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first5 appearances

  1. 2019

    2 rounds

  2. Dec
    Kinnate BiopharmaSeries B · US · FinSMEs$75MWith 4 others
  3. Jul
    ArunA BioUS · FinSMEs$13MSole investor
  4. 2015

    3 rounds

  5. Apr
    Innocrin PharmaceuticalsSeries D · US$28MSole investor
  6. Feb
    G1 Therapeutics, Inc.Series B · US$33MWith 5 others
  7. Feb
    Dignify TherapeuticsVenture · US$3.0MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What they claim to have backed

From their own portfolio page (on their website)

6 of 13 we have independently watched raise

Aruna BioCavalryDignify TherapeuticsJupiter BioventuresParadigm TherapeuticsSapience TherapeuticsBreakthru MedicineCarbonGenesisKOMO BiosciencesMed AditusPhoenix Molecular DesignsWilmingtondesignco

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Who they invest alongside

The investors most often in the same rounds as Eshelman Ventures. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Eshelman Ventures

What does Eshelman Ventures invest in?

Eshelman Ventures invests most often at Series B and Series D (75% of the rounds on record), in sectors such as Wellbeing, Healthier Living and Well-being.

How active is Eshelman Ventures?

5 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2019.

What has Eshelman Ventures invested in recently?

Its most recent investments on record: Kinnate Biopharma (Series B, Dec 2019) and ArunA Bio (Undisclosed round, Jul 2019).

How big are Eshelman Ventures's cheques?

The median round it joins is $44M.

Does Eshelman Ventures lead rounds?

Rarely, if at all: none of its 5 investments on record names it as the lead.

Where does Eshelman Ventures invest?

Most of the companies it backs are in the United States (100%).

Is Eshelman Ventures investing now?

No investments in the last 12 months; the latest was in Dec 2019.

Who does Eshelman Ventures invest alongside?

Most often RA Capital Management (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it